SecBot SecBot
6-K ·Filed May 15, 2026

GIKLY

Grifols SA
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001104659-26-062230
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine governance filing with no immediate trading catalyst. Monitor the shareholder meeting for any unexpected proposals or activist activity. The NASDAQ listing renewal and capital reduction authorization are structural but not price-moving in the near term.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GIKLY ▼ -3.77% at T+60d
NEUTRAL call -3.77% · α vs SPY -8.29% · entry $5.30 → $5.10
Entry = T+0 close
May 15, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.06%
$5.30
settled 5mo ago
T+5d
0.00%
call 0.00% · α -0.96%
$5.30
settled 5mo ago
T+20d
+7.36%
call +7.36% · α +5.24%
$5.69
settled 4mo ago
T+60d
-3.77%
call -3.77% · α -8.29%
$5.10
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Grifols filed a 6-K on May 15, 2026, calling an Ordinary General Shareholders' Meeting for June 17-18, 2026. The agenda includes routine items such as approval of FY2025 accounts, re-election of Deloitte as auditor, re-election of two board members, and authorization for a share capital reduction of up to 10% via redemption of treasury shares. The filing also seeks renewal of authority to list Class A shares on NASDAQ and delegation to increase share capital by up to 50% with possible pre-emptive rights exclusion. No financial results or material operational updates are disclosed.

Key Facts

  • Ordinary General Shareholders' Meeting called for June 17, 2026 (first call) and June 18, 2026 (second call).
  • Agenda includes approval of FY2025 annual accounts, re-election of Deloitte as auditor for 2027-2029, and re-election of two board members.
  • Proposal to reduce share capital by up to 10% via redemption of treasury Class A and Class B shares.
  • Renewal of delegation to seek NASDAQ listing for Class A shares.
  • Authorization sought to increase share capital by up to 50% over five years, with possible exclusion of pre-emptive rights up to 20%.
  • No financial results, guidance, or material business developments reported.

Financial Impact

No financial figures disclosed; capital reduction up to 10% of share capital via treasury share redemption.

share countcapital structure

Risk Factors

  • Potential dilution if share capital increase with pre-emptive rights exclusion is exercised.
  • No material financial or operational updates — filing is procedural.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-062230
Document: 0001104659-26-062230-index-headers.html0001104659-26-062230
Document: 0001104659-26-062230-index.html0001104659-26-062230
Document: 0001104659-26-062230.txt0001104659-26-062230
3 reports for GIKLY
Performance horizon
Filters
Rows
Reports for GIKLY — sortable, filterable
TypeNow
May 15, 2026
23w ago
6-K
NEUTRAL ★ 3/10
$5.30 $5.69▲ +7.36%▲ +5.24%$5.55 (+4.72%)
May 7, 2026
24w ago
6-K
MIXED ★ 5/10
$5.30 $5.69▲ +7.36%▲ +4.22%$5.55 (+4.72%)
Apr 17, 2026
27w ago
20-F
MIXED ★ 6/10
$5.74 $5.30▼ −7.67%▼ −11.87%$5.55 (−3.31%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 7h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026